Archive26 August 2022
This is the first European Society of Cardiology (ESC) guideline on cardio-oncology.
The aim of this guideline is to help all the healthcare professionals providing care to oncology patients before, during,
and after their cancer treatments with respect to their cardiovascular health and wellness.
This guideline provides guidance on the definitions, diagnosis, treatment, and prevention of cancer therapy-related
CV toxicity, and the management of CV disease caused directly or indirectly by cancer.
The full text is available at the European Heart Journal website.
View linked resource →